ArticleEBioMedicine2018

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.

Violaine K Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.